306 related articles for article (PubMed ID: 15230672)
1. Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab.
López San Román A; Bermejo F; Aldanondo I; Carrera E; Boixeda D; Muñoz Zato E
Rev Esp Enferm Dig; 2004 Jun; 96(6):420-2; 422-4. PubMed ID: 15230672
[TBL] [Abstract][Full Text] [Related]
2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases.
Cocco A; Angelucci E; Viscido A; Caprilli R
Inflamm Bowel Dis; 2007 Oct; 13(10):1317-9. PubMed ID: 17508417
[No Abstract] [Full Text] [Related]
4. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.
Ueda M; Katoh M; Tanizaki H; Tanioka M; Matsumura Y; Miyachi Y
Dermatol Online J; 2012 Jan; 18(1):12. PubMed ID: 22301049
[TBL] [Abstract][Full Text] [Related]
5. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
[TBL] [Abstract][Full Text] [Related]
6. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of pyoderma gangrenosum and Sweet's syndrome in a patient with ulcerative colitis.
Castro-Fernández M; Sánchez-Muñoz D; Ruíz-Granados E; Merchante N; Corzo J
Am J Gastroenterol; 2007 Dec; 102(12):2865-6. PubMed ID: 18042124
[No Abstract] [Full Text] [Related]
8. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
[TBL] [Abstract][Full Text] [Related]
9. A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery.
Andrisani G; Guidi L; Papa A; Potenza AE; Cervelli D; Armuzzi A
J Crohns Colitis; 2013 Jun; 7(5):421-6. PubMed ID: 22889645
[TBL] [Abstract][Full Text] [Related]
10. Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis.
Ermis F; Ozdil S; Akyüz F; Pinarbasi B; Mungan Z
Inflamm Bowel Dis; 2008 Nov; 14(11):1611-3. PubMed ID: 18401859
[No Abstract] [Full Text] [Related]
11. [Infliximab for a girl with refractory pyoderma gangrenosum].
Nozawa T; Hara R; Kinoshita J; Sano F; Miyamae T; Imagawa T; Mori M; Hirokado M; Takahashi K; Inayama Y; Yokota S
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Dec; 31(6):454-9. PubMed ID: 19122376
[TBL] [Abstract][Full Text] [Related]
12. Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis.
Teich N; Klugmann T
J Crohns Colitis; 2014 Jan; 8(1):85-6. PubMed ID: 23810275
[No Abstract] [Full Text] [Related]
13. [Infliximab treatment of peristomal pyoderma gangrenosum in ulcerative colitis].
Nybaek H; Jemec GB
Ugeskr Laeger; 2005 Aug; 167(32):2920-1. PubMed ID: 16109221
[No Abstract] [Full Text] [Related]
14. Refractory and infected pyoderma gangrenosum in a patient with ulcerative colitis: response to infliximab.
De la Morena F; Martín L; Gisbert JP; Fernández Herrera J; Goiriz R
Inflamm Bowel Dis; 2007 Apr; 13(4):509-10. PubMed ID: 17206663
[No Abstract] [Full Text] [Related]
15. Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis.
Fernández A; Velasco A; Prieto V; Canueto J; Alvarez A; Rodríguez A
Am J Gastroenterol; 2008 Nov; 103(11):2951-2. PubMed ID: 19032482
[No Abstract] [Full Text] [Related]
16. Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: don't forget the role of cyclosporin.
Sinagra E; Orlando A; Renna S; Maida M; Cottone M
Inflamm Bowel Dis; 2012 Aug; 18(8):E1594-5. PubMed ID: 22038892
[No Abstract] [Full Text] [Related]
17. [Pyoderma gangrenosum treated successfully with visilizumab in patients with ulcerative colitis].
Lorincz M; Kleszky M; Szalóki T; Szalóki T
Orv Hetil; 2010 Jan; 151(4):144-7. PubMed ID: 20071320
[TBL] [Abstract][Full Text] [Related]
18. Infliximab for treatment of pyoderma gangrenosum with ulcerative colitis.
Joob B; Wiwanikit V
J Crohns Colitis; 2013 May; 7(4):e153. PubMed ID: 22981616
[No Abstract] [Full Text] [Related]
19. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
Kujundzić M
Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
[TBL] [Abstract][Full Text] [Related]
20. Pyoderma gangrenosum and ulcerative colitis in the tropics.
Alese OB; Irabor DO
Rev Soc Bras Med Trop; 2008; 41(6):664-7. PubMed ID: 19142449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
